ID   NLGIP-5519
AC   CVCL_JB37
DR   GEO; GSM1517015
DR   Wikidata; Q54930782
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   https://en-med.tau.ac.il/nlgip
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Lybian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
RX   CelloPub=CLPUB00389;
RA   Chouchana L.;
RT   "Optimization of thiopurine response by pharmacogenetics: in vitro and
RT   clinical approaches.";
RL   Thesis PhD (2014); Universite Paris Descartes; Paris; France.
//
RX   PubMed=20235789; DOI=10.2217/pgs.10.27;
RA   Morag A., Stingl J.C., Rehavi M., Gurwitz D.;
RT   "Human lymphoblastoid cell line panels: novel tools for assessing
RT   shared drug pathways.";
RL   Pharmacogenomics 11:327-340(2010).
//
RX   PubMed=26015807; DOI=10.1186/s13073-015-0150-6; PMCID=PMC4443628;
RA   Chouchana L., Fernandez-Ramos A.A., Dumont F., Marchetti C.,
RA   Ceballos-Picot I., Beaune P., Gurwitz D., Loriot M.-A.;
RT   "Molecular insight into thiopurine resistance: transcriptomic
RT   signature in lymphoblastoid cell lines.";
RL   Genome Med. 7:37.1-37.12(2015).
//